Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48
March 25, 2026
Pasithea Therapeutics Opens Second Ketamine Therapy Clinic in the United Kingdom
December 21, 2021
Related Post
-
-
BeyondSpring Reports 2025 Year-End Financial Results
March 25, 2026
-
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program
March 24, 2026
-
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement
March 23, 2026